Study of biological markers with possible prognostic implication in lymphoproliferative diseases: use of cytogenetic, molecular biology and immunophenotyping techniques

• Grant number: 96/01441-3
• Support Opportunities: Research Projects - Thematic Grants
• Start date: January 01, 1997
• End date: March 31, 2000
• Field of knowledge: Health Sciences - Medicine - Medical Clinics
• Principal Investigator: Dalton de Alencar Fischer Chamone
• Grantee: Dalton de Alencar Fischer Chamone
• Host Institution: Hemocentro de São Paulo. Fundação Pró-Sangue. Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil

Abstract

Onco-hematological illnesses have been re-evaluated recently in the light of new prognostic factors which will emerge from recently obtained knowledge about the biology of these disturbances. We intend to analyze new prognostic factors in myeloma and lymphoproliferations by means of cytogenetics, immunophenotyping and molecular biology, correlating these with classic factors (clinical findings, staging, cytomorphology) between themselves, with response to chemotherapy and survival expectancy. (AU)

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

GARICOCHEA‚ B.; GIORGI‚ R.; ODONE‚ V.F.; DORLHIAC-LLACER‚ P.E.; BENDIT‚ I.. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Leukemia Research, v. 22, n. 11, p. 1003-1007, 1998. (96/01441-3)